A glycoengineered therapeutic anti-HBV antibody that allows increased HBsAg immunoclearance improves HBV suppression in vivo by Min You, Fentian Chen, Chao Yu, Yuanzhi Chen, Yue Wang, Xue Liu, Xueran Guo, Bing Zhou, Bing Zhou, Xin Wang, Xin Wang, Boya Zhang, Mujin Fang, Mujin Fang, Tianying Zhang, Tianying Zhang, Ping Yue, Yingbin Wang, Yingbin Wang, Quan Yuan, Quan Yuan, Wenxin Luo, Wenxin Luo

Connect to this object online.